|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/74 | |
| A61K 38/16 | |||
| A61K 38/00 | |||
| A61K 9/00 | |||
| A61K 9/06 | |||
| A61K 47/38 | |||
| A61K 38/17 |
| (11) | Number of the document | 2819682 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13755720.3 |
| Date of filing the European patent application | 2013-03-01 | |
| (97) | Date of publication of the European application | 2015-01-07 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/028727 |
| Date | 2013-03-01 |
| (87) | Number | WO 2013/131040 |
| Date | 2013-09-06 |
| (30) | Number | Date | Country code |
| 201261605528 P | 2012-03-01 | US |
| (72) |
GHATNEKAR, Gautam, US
|
| (73) |
Firststring Research, Inc.,
300 West Coleman Blvd. Suite 203, Mount Pleasant, SC 29464,
US
|
| (54) | TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES |
| TOPICAL GELS CONTAINING ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES |